Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?-Reference-Cited by-同舟云学术

Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?

Published:2021-01-30 Issue:7 Volume:268 Page:2458-2465
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Roos-Weil Damien^ORCID,Weiss Nicolas,Guihot Amélie,Uzunov Madalina,Bellanger Agnès,Eymard Bruno,Saadoun David,Houillier Caroline,Idbaih Ahmed,Demeret Sophie,Deback Claire,Leblond Véronique,Galanaud Damien,Shor Natalia,Pourcher Valérie

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-021-10414-y.pdf

Reference10 articles.

1. Kartau M, Verkkoniemi-Ahola A, Paetau A et al (2019) The incidence and predisposing factors of John Cunningham virus-induced progressive multifocal leukoencephalopathy in Southern Finland: a population-based study. Open Forum Infect Dis 6:ofz024

2. Cortese I, Muranski P, Enose-Akahata Y et al (2019) Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med 380:1597–1605

3. Uzunov M, Demeret S, Nguyen-Quoc S et al (2020) Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab. Br J Haematol 188:e82–e84

4. Walter O, Treiner E, Bonneville F et al (2019) Treatment of progressive multifocal leukoencephalopathy with nivolumab. N Engl J Med 380:1674–1676

5. Barber DL, Wherry EJ, Masopust D et al (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682–687

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosis;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2024-04

2. Progressive multifocal leukoencephalopathy in patients with chronic liver disease successfully treated with pembrolizumab;Journal of Neurology;2023-12-24

3. Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod;Journal of Neurology;2023-11-01

4. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China;Journal of NeuroVirology;2023-10-28

5. Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim;Journal of Neurology;2023-07-17